ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 27 filers reported holding ONCTERNAL THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,000 | +73.9% | 10,000 | +100.0% | 0.00% | – |
| Q2 2023 | $1,725 | -56.1% | 5,000 | 0.0% | 0.00% | – |
| Q1 2023 | $3,925 | -21.5% | 5,000 | 0.0% | 0.00% | – |
| Q4 2022 | $5,000 | +25.0% | 5,000 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | -33.3% | 5,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $6,000 | -14.3% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $7,000 | -36.4% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $11,000 | -47.6% | 5,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $21,000 | -12.5% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $24,000 | -42.9% | 5,000 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $42,000 | +75.0% | 5,000 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $24,000 | +242.9% | 5,000 | +25.0% | 0.00% | +100.0% |
| Q3 2020 | $7,000 | -36.4% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $11,000 | -8.3% | 4,000 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $12,000 | -36.8% | 4,000 | -18.4% | 0.00% | 0.0% |
| Q4 2019 | $19,000 | -20.8% | 4,900 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $24,000 | – | 4,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Richmond Brothers, Inc. | 494,042 | $148,212 | 0.28% |
| Quantum Private Wealth, LLC | 459,187 | $137,757 | 0.07% |
| Pasadena Private Wealth, LLC | 278,750 | $83,625 | 0.02% |
| Beta Wealth Group, Inc. | 32,000 | $9,600 | 0.01% |
| BRIGHTON JONES LLC | 338,491 | $101,548 | 0.01% |
| Balboa Wealth Partners | 47,500 | $14,250 | 0.01% |
| Waypoint Capital Advisors, LLC | 26,271 | $7,882 | 0.00% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 53,554 | $16,243 | 0.00% |
| Aureus Asset Management, LLC | 30,211 | $9,063 | 0.00% |
| AXXCESS WEALTH MANAGEMENT, LLC | 70,363 | $21,109 | 0.00% |